🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to evaluate the efficacy and safety of Etoric...
Status
Completed
Location
Multiple Locations
Start Date
2008-12-15
Trial ID
NCT00820027
The purpose of this study is to test the effect of ibuprofen on the levels ...
Status
Unknown
Location
Layton Aging & Alzheimer's Disease Center
Start Date
2005-10
Trial ID
NCT00239746
To compare the efficacy and safety of celecoxib versus ibuprofen in subject...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2003-01
Trial ID
NCT00630929
The purpose of this trial is to established the safety and efficacy of mult...
Status
Completed
Location
Jean Brown Research
Start Date
2011-09
Trial ID
NCT01435577
Treatments Being Tested
To compare the safety and efficacy of celecoxib versus placebo in the treat...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2003-12
Trial ID
NCT00640627
This is a 2x2, within-subjects, cross-over trial to test the anti-depressan...
Status
Recruiting
Location
Laureate Institute for Brain Research
Start Date
2024-03-12
Trial ID
NCT06088732
Treatments Being Tested
To compare the efficacy and safety of celecoxib versus placebo for the trea...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2003-12
Trial ID
NCT00638807
The use of oral ibuprofen combined with Opioid (Morphine or Diamorphine) ad...
Status
Terminated
Location
North West London Hospitals NHS Trust
Start Date
2011-03
Trial ID
NCT00880373
Treatments Being Tested
This is a randomized clinical trial comparing two interventions for acute l...
Status
Completed
Location
Montefiore Medical Center
Start Date
2018-10-16
Trial ID
NCT03554018
Treatments Being Tested
To compare the efficacy and safety of celecoxib versus ibuprofen in subject...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2002-10
Trial ID
NCT00620867